Beijing, Dec 10, 2007 AEST (ABN Newswire) - HELICON GROUP LIMITED (ASX: HCG) signed a cooperation agreement with Jewim Pharmaceuticals Inc, a leading player in the Chinese pharmaceutical industry.
The deal, signed with Beijing based Jewim Pharmaceuticals Inc., is designed to draw on the strengths of each party in successfully bringing new biomedical technologies to the China market.
Jewim Pharmaceuticals Inc. is a privately held group established in 1979.
Employing over 800 people in the manufacturing, distribution, research, sales and marketing areas, the Groups' core business revolves around the distribution and associated services to major multinationals in the Chinese oncology and transplantation markets. Representing such majors as Novartis, Astra Zeneca and Wyeth, Jewim is the largest distributor of pharmaceuticals and devices to Chinese oncology units with for example 100% coverage to the hospitals with Oncology units in the larger cities of Shanghai, Beijing and Guangzhou.
Helicon has identified the Chinese oncology segment as one of its target markets and is actively seeking oncology related technologies to add to its portfolio "We are very pleased to establish this relationship with the Helicon Group. This relationship will provide Jewim with access to ongoing stream of Western state of the art medical technologies for commercialisation in China" said Dr. Song Gengfu, President of Jewim Pharmaceuticals Inc at the formal signing ceremony in Beijing.
"This alliance with Jewim Pharmaceuticals is yet another step in Helicon's strategy to build its capability with alliances with established partners in the specialist areas such as the highly lucrative oncology market in China. Jewim will provide Helicon with the necessary leverage to gain rapid market penetration with its extensive distribution and marketing capability." said Peter Abrahamson, Helicon's CEO in response.
About Jewim Pharmaceuticals Inc.
Jewim Pharmaceutical Inc.'s core business revolves around the distribution of pharmaceuticals in China on behalf of a number of foreign multinationals. Jewim has a number of other associated businesses including an R&D capability, manufacturing, pharmacy chain distribution as well as the best Chinese e-pharmacy network. The overall business is in the manufacture, research, sales and distribution of medical products, which include medicines, medical devices, medical equipment, medical treatment facilities and technologies, diagnostic equipment and materials, materials relating to the pharmaceutical industries and other similar items.
Contact
Peter Abrahamson
Helicon Group Limited
Level 1, 173 Mounts Bay Road Perth WA 6000
Tel: +61 411 336 330
Email: peter@helicongroup.com.au
Website: www.helicongroup.com.au
| ||
|
